Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr

Verify with FDA CVM →

50 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
50
Total Reports
47
Deaths Reported
9400.0%
Death Rate

Active Ingredients

Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr

Administration Routes

SubcutaneousUnknownNasal

Species Affected

Cattle 50

Most Affected Breeds

Mixed (Cattle) 47
Aberdeen Angus 2
Salers 1

Most Reported Reactions

Death 46
Lack of efficacy - NOS 40
Necropsy performed 19
Lack of efficacy (mycoplasma) - NOS 5
Lack of efficacy (bacteria) - Histophilus somni 4
Lack of efficacy (bacteria) - Mannheimia haemolytica 4
Lack of efficacy (virus) - bovine viral diarrhoea virus 4
Malaise 3
Pulmonary disorder NOS 3
Systemic disorder NOS 2
Intentional misuse 2
Musculoskeletal disorder NOS 2

Outcome Breakdown

Died
47 (54.0%)
Outcome Unknown
21 (24.1%)
Ongoing
16 (18.4%)
Recovered/Normal
3 (3.4%)

Data Summary

Metric Value
Total adverse event reports 50
Reports involving death 47
Case-fatality rate (reported events) 9400.0%
Distinct species in reports 1
Distinct breeds in reports 3
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 50 adverse event reports referencing Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr, including 47 reports in which the animal died — a 9400.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr. Reported administration routes include Subcutaneous, Unknown, Nasal. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr reports are Cattle (50 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (47), Aberdeen Angus (2), Salers (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr are Death (46), Lack of efficacy - NOS (40), Necropsy performed (19), Lack of efficacy (mycoplasma) - NOS (5). Of the 87 reports with a coded outcome, Died is the leading category at 54.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Bovine Viral Diarrhea Virus, Type 1, Strain Nadl-Sbvd, Msvx+1;Bovine Viral Diarr.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial